Gryphon Investors–backed Metagenics acquired leading UK probiotic supplement brand Symprotalive.WHO: Founded by Barry Smith on his Surrey farm in 2010, Symproveis the UK's number-one probiotic and the one most recommended by healthcare practitioners. Symprove's liquid format, containing live, active multi-strain bacteria, supported by its patented delivery system that allows the bacteria to "arrive, survive and thrive" in the gut, is recognized as uniquely effective by some of the world's leading academics.Founded in 1983 and based in Aliso Viejo, California, with facilities across North America, Europe, Asia, and Australia, Metagenics is a leading global nutritional supplement company. For over 40 years, Metagenics has delivered high-quality, science-based nutritional supplements, medical foods, and lifestyle programs to support healthcare practitioners as they help patients achieve health and wellness goals. They boast a heritage of breakthrough science, innovative products, practitioner education, and dedicated partnerships.IN THEIR OWN WORDS: Ryan Fagan, Deal Partner in Gryphon's Consumer Group, said, "We have never been more excited for the future of Metagenics. Symprove's differentiated product is highly strategic for Metagenics' portfolio of practitioner-recommended supplements. Through its global network of partnerships with healthcare practitioners, Metagenics will be able to grow patient engagement and improve patient results with Symprove's technology in markets around the world. This acquisition is a significant inflection point for our partnership with Metagenics, and we are eager to pursue similar strategic acquisition opportunities.